[1] Richman D D, Margolis D M, Delaney M, et al. The challenge of finding a cure for HIV infection. Science, 2009, 323 (5919):1304-1307.
[2] Le Grand R, Bosquet N, Dispinseri S, et al. Superior efficacy of an HIV vaccine combined with ARV prevention in SHIV challenged non-human primates. J Virol, 2016, 90(11):5315-5328.
[3] Antony J M, Macdonald K S. A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy. Vaccine, 2015, 33 (27):3073-3083.
[4] Jia X, Zhao Q, Xiong Y. HIV suppression by host restriction factors and viral immune evasion. Curr Opin Struct Biol, 2015, 31:106-114.
[5] Evans M E, Kumkhaek C, Hsieh M M, et al. TRIM5alpha variations influence transduction efficiency with lentiviral vectors in both human and rhesus CD34(+) cells in vitro and in vivo. Mol Ther, 2014, 22 (2):348-358.
[6] Campbell E. Are we done monkeying around with TRIM5alpha? Mol Ther, 2014, 22 (6):1072-1073.
[7] Stremlau M, Owens C M, Perron M J, et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old world monkeys. Nature, 2004, 427 (6977):848-853.
[8] Nakayama E E, Shioda T. TRIM5alpha and species tropism of HIV/SIV. Front Microbiol, 2012, 3:13.
[9] Mccarthy K R, Kirmaier A, Autissier P, et al. Evolutionary and functional analysis of old world primate TRIM5 reveals the ancient emergence of primate lentiviruses and convergent evolution targeting a conserved capsid Interface. PLoS Pathog, 2015, 11 (8):e1005085.
[10] Puvvada M P, Patel S S. Role of trim5alpha in the suppression of cross-species transmission and its defence against human immunodeficiency virus. Curr HIV Res, 2013, 11 (8):601-609.
[11] Mussolino C, Alzubi J, Fine E J, et al. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Nucleic Acids Res, 2014, 42 (10):6762-6773.
[12] Wei C, Liu J, Yu Z, et al. TALEN or Cas9——rapid, efficient and specific choices for genome modifications. J Genet Genomics, 2013, 40 (6):281-289.
[13] Malim M H, Bieniasz P D. HIV restriction factors and mechanisms of evasion. Cold Spring Harb Perspect Med, 2012, 2 (5):a006940.
[14] Harris R S, Hultquist J F, Evans D T. The restriction factors of human immunodeficiency virus. J Biol Chem, 2012, 287 (49):40875-40883.
[15] Richardson M W, Guo L, Xin F, et al. Stabilized human TRIM5alpha protects human T cells from HIV-1 infection. Mol Ther, 2014, 22 (6):1084-1095.
[16] Nakayama E E, Shioda T. Impact of TRIM5alpha in vivo. AIDS, 2015, 29 (14):1733-1743.
[17] Yap M W, Nisole S, Stoye J P. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr Biol, 2005, 15 (1):73-78. |